Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-03

Clinical Trial Update: Study on Mastocytosis for Rupatadine Treatment [Phase 2, Phase 3]

View source ↗

Summary

This document reports the completion of phase 2 and phase 3 trials evaluating rupatadine as a treatment for mastocytosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rupatadine (rupatadine)

Snippet

Sponsor: Marcus Maurer | Conditions: Mastocytosis | Phase 2, Phase 3 | Status: COMPLETED